First Bundibugyo Ebola vaccine to start human trials in the UK

Researchers in Oxford are gearing up to test the first vaccine against Bundibugyo Ebola, a rare strain that's causing concern as it spreads across Congo and Uganda. This move is significant because it marks the first time a vaccine for this particular virus has entered human trials. The urgency is heightened by the ongoing outbreak, underscoring the need for effective prevention methods. This development could set a precedent for tackling other rare Ebola strains, potentially saving lives in future outbreaks.